Changzhou Qianhong Biopharma CO.,LTD EBITDA Margin for the year ending December 31, 2024: 30.32%

Changzhou Qianhong Biopharma CO.,LTD EBITDA Margin is 30.32% for the year ending December 31, 2024, a 94.45% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Changzhou Qianhong Biopharma CO.,LTD EBITDA Margin for the year ending December 31, 2023 was 15.59%, a -18.86% change year over year.
  • Changzhou Qianhong Biopharma CO.,LTD EBITDA Margin for the year ending December 31, 2022 was 19.22%, a 28.01% change year over year.
  • Changzhou Qianhong Biopharma CO.,LTD EBITDA Margin for the year ending December 31, 2021 was 15.01%, a -432.26% change year over year.
  • Changzhou Qianhong Biopharma CO.,LTD EBITDA Margin for the year ending December 31, 2020 was -4.52%, a -120.65% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin